XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Research and development $ 26,590 $ 69,637 $ 89,423
General and administrative 68,800 71,809 16,534
Total operating expenses 95,390 141,446 105,957
Operating loss (95,390) (141,446) (105,957)
Interest income 4,620 8,510 7,833
Other income (loss), net (203) 411 907
Gain from change in fair value of warrant liabilities 0 108,183 0
Net loss $ (90,973) $ (24,342) $ (97,217)
Shares used in computing net loss per share, basic (in shares) 48,297 46,329 41,932
Net loss per share, basic (in dollars per share) $ (1.88) $ (0.53) $ (2.32)
Net loss $ (90,973) $ (24,342) $ (97,217)
Adjustment for change in fair value of warrant liabilities 0 (43,793) 0
Adjusted numerator, diluted $ (90,973) $ (68,135) $ (97,217)
Shares used in computing net loss per share, diluted (in shares) 48,297 46,604 41,932
Net loss per share, diluted (in dollars per share) $ (1.88) $ (1.46) $ (2.32)